A necessary step toward complete functional recovery after spinal cord injury is the regeneration of axons. Axon regrowth after injury is prevented by a myriad of intrinsic and extrinsic factors. In this issue of The EMBO Journal, Huang et al (2016) demonstrate that the cell adhesion molecule NB-3 (CNTN6) functions as a major brake on axon regrowth when it is activated by NB-3 from scar-forming cells at the injury site. Disruption of this NB-3 trans-cellular signaling led to impressive axon regrowth after spinal cord transection.
See also: Z Huang et al (August 2016) N B-3 is a member of the contactin subfamily within the immunoglobulin superfamily (IgSF) of cell adhesion molecules (CAMs). IgSF CAMs regulate axon growth, branching, and synapse formation and plasticity in the developing and mature nervous system (Leshchyns'ka & Sytnyk, 2016) . Members of the contactin subfamily interact with proteins of the L1cam IgSF subfamily, and both families play essential functions in neuronal network formation in the developing nervous system (Kamiguchi et al, 1998; Wei & Ryu, 2012) .
IgSF CAMs are involved in intricate webs of signaling (Fig 1A) . They can form interactions in cis with other molecules in the same membrane or in trans with molecules on adjacent cells. These interactions can also be with the same CAM (homophilic) or with different molecules (heterophilic) (Maness & Schachner, 2007) . As receptors, they can transduce signals via a variety of intracellular partners (Herron et al, 2009 ) that often result in cytoskeletal remodeling (Leshchyns'ka & Sytnyk, 2016) . Thus, IgSF CAMs represent promising targets to trigger axon regeneration following CNS injury. However, their diverse binding partners result in immense difficulty in understanding which components work together to regulate specific biological processes, especially in vivo. But Huang and colleagues managed to succeed with NB-3. An overview of the model of interactions they propose is shown in Fig 1B . Huang et al (2016) observed that while NB-3 was weakly expressed throughout the intact mouse spinal cord, it was strongly upregulated at the lesion site after a spinal cord transection. The authors determined that NB-3 was produced not only by astrocytes, but also by pericytes and fibroblasts at the lesion site. Importantly, NB-3 expression was also increased in the axons of the injured corticospinal neurons.
The authors next demonstrated that knockout of NB-3 greatly improved the regrowth of corticospinal axons after injury. Rather than retraction of axons from the lesion site, they observed many axons growing into and through the lesion site of the spinal cord postinjury. This enhanced axonal growth in the NB-3 knockout mice was accompanied by improved behavior, electrophysiological continuity, and synapse formation distal to lesion site. This surprising response to spinal transection raised many questions about how NB-3 exerts its anti-regenerative effects on axons.
Huang et al (2016) first performed a series of in vivo spinal transection experiments to solve this puzzle. First, they demonstrated that shRNA knockdown of NB-3 in either the cortex or the lesion site phenocopied the axon regenerative result seen in the NB-3 knockout mice. This suggested that NB-3 is needed both in neurons and scar-forming cells to exert its anti-regenerative effects on the neurons. Expression of NB-3 in the cortex or at the lesion site in NB-3 knockout mice did not diminish axon regrowth after a spinal cord transection. But when NB-3 was exogenously expressed in both the cortex and the lesion site of NB-3 knockout mice, this lead to no axon regeneration.
Armed with the hypothesis that NB-3 trans-cellular signaling exerts antiregenerative effects on injured corticospinal axons, Huang et al (2016) moved in vitro to show a direct, causative effect of NB-3 transcellular signaling on axon growth. They performed co-culture experiments using embryonic cortical neurons and postnatal day 1-3 cortical astrocytes. Removal of NB-3 from either or both of these cell types resulted in greatly enhanced neurite outgrowth on the astrocytes demonstrating that NB-3 was required in both neurons and astrocytes in order to inhibit neurite outgrowth on astrocytes.
It was previously shown that CHL1 and PTPa form a complex with NB-3 (Ye et al, 2008) . The expressions of CHL1 and PTPr, a paralog of PTPa, increase after spinal transection and both factors co-localize with NB-3. Immunoprecipitating NB-3 from the spinal lesion site revealed an interaction with CHL1. shRNA knockdown of CHL1 in both the cortex and the lesion site is sufficient to enhance axon regrowth. Knockdown of CHL1 after spinal transection in the NB-3 knockout mice did not further enhance axon regrowth. Immunoprecipitants for NB-3 from sensorimotor cortical areas contained PTPr. Knockdown of PTPr using shRNA in the cortex is also sufficient to enhance axon regrowth to a similar extent seen in the CHL1 knockdown experiment. Taken together, this is strong evidence that NB-3 works with CHL1 and PTPr to inhibit axon growth at the injury site.
Finally, Huang et al (2016) set out to identify the intracellular signaling pathways downstream of NB-3 and its two partners used to halt axon growth. They hypothesized that NB-3 trans-cellular signaling antagonized axon regrowth by inhibiting the mTOR pathway. Immunofluorescence and Western blotting analysis demonstrated that AktmTOR activity is increased following injury in NB-3 knockout mice. However, the authors do not demonstrate (i) by what direct or indirect signaling pathway PTPr inhibits Akt activity, (ii) whether the relief of such a brake on Akt signaling would be sufficient to cause the amount of axon regrowth observed in this article, or (iii) that the relief of a similar brake on Akt signaling (such as removing PTEN) would lead to less than additive effects on axon regrowth. The signaling from PTPr to Akt will be particularly important for determining what other pathways the NB-3 signaling complex may be affecting.
As is often observed in spinal cord injury papers where axon regrowth is achieved, the axons in this study manage to grow through the glial scar, but avoid the fibrotic scar (Liu et al, 2010) . This article serves as an important reminder that postinjury astrocytes may not be as detrimental for axon growth as once thought (Anderson et al, 2016) .
A final question arising from this finding is what prevents axon to axon trans-cellular activation of NB-3 signaling? Since this would prevent any axon extension in NB-3-containing neurons, the data in this article indirectly demonstrate that such trans-neuronal NB-3 signaling is either not occurring or does not have the same antiregenerative effects as neuron-astrocyte NB-3 signaling. Further research should investigate what aspects of the complex composition allow for such a differential signaling result. Huang et al (2016) compiles an enormous amount of work that convincingly demonstrates that NB-3 trans-cellular signaling between neurons and scar-forming cells after a spinal cord transection functions as a brake on axon regeneration. The release of The NB-3 signaling complex in axon regeneration. This figure conceptually diagrams the model of NB-3 neuron-astrocyte signaling proposed by Huang et al (2016) . The growth cone of an axon contacts an astrocyte at the lesion site. The neuron contains complexes of NB-3, CHL1, and PTPr interacting in cis. The astrocyte contains complexes of NB-3 and CHL1. These two complexes interact in trans to block axon regeneration. 
